Dr Deadstock Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 09081981

Dr Deadstock Limited

Filleted Unaudited Financial Statements

31 March 2026

Dr Deadstock Limited

Financial Statements

Year ended 31 March 2026

Contents	Page

Statement of financial position	1

Notes to the financial statements	3

Dr Deadstock Limited

Statement of Financial Position

31 March 2026

	2026		2025
Note	£	£	£

Fixed assets

Tangible assets	5		1,111	1,910

Current assets

Stocks		14,653	14,653
Debtors	6	519	–
Cash at bank and in hand		41,680	20,840
		--------	--------
		56,852	35,493

Creditors: amounts falling due within one year	7	41,889		35,605
		--------		--------
Net current assets/(liabilities)			14,963	( 112)
			--------	-------
Total assets less current liabilities			16,074	1,798
			--------	-------
Net assets			16,074	1,798
			--------	-------

Capital and reserves

Called up share capital	8	100	100
Profit and loss account		15,974	1,698
		--------	-------
Shareholders funds		16,074	1,798
		--------	-------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Dr Deadstock Limited

Statement of Financial Position (continued)

31 March 2026

These financial statements were approved by the board of directors and authorised for issue on 16 August 2026 , and are signed on behalf of the board by:

Dr A S Crozier	Mr I J Crozier
Director	Director

Company registration number: 09081981

Dr Deadstock Limited

Notes to the Financial Statements

Year ended 31 March 2026

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 146 New London Road, Chelmsford, Essex, CM2 0AW, England.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

The financial statements have been prepared on a going concern basis which is dependent upon the continued support of the directors. The directors have expressed their willingness to support the company for the foreseeable future by ensuring sufficient funds are available for the company to continue trading.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Equipment	-	25% straight line

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 2 (2025: 2 ).

5. Tangible assets

	Equipment	Total
	£	£
Cost
At 1 April 2025 and 31 March 2026	11,243	11,243
	--------	--------
Depreciation
At 1 April 2025	9,333	9,333
Charge for the year	799	799
	--------	--------
At 31 March 2026	10,132	10,132
	--------	--------
Carrying amount
At 31 March 2026	1,111	1,111
	--------	--------
At 31 March 2025	1,910	1,910
	--------	--------

6. Debtors

	2026	2025
	£	£
Prepayments and accrued income	519	–
	----	----

7. Creditors: amounts falling due within one year

	2026	2025
	£	£
Accruals and deferred income	1,896	1,806
Corporation tax	39,993	33,677
Director loan accounts	–	122
	--------	--------
	41,889	35,605
	--------	--------

8. Called up share capital

Issued, called up and fully paid

	2026		2025
	No.	£	No.	£
Ordinary shares of £ 1 each	100	100	100	100
	----	----	----	----

9. Related party transactions

At the year end, the company owed the directors £nil (2025: £122).